ProDerma

At ProDerma in Dülmen, Germany, much of the research focuses on skin and connective tissue diseases, especially psoriasis, atopic dermatitis, acne, and rosacea. These studies are designed to test new treatments, compare them with established options, and improve symptom control for common inflammatory skin conditions.

• Studies in plaque psoriasis and mild-to-moderate psoriasis are evaluating whether new therapies can improve disease control and support better long-term management.
• Research in atopic dermatitis is looking at ways to reduce flares, relieve inflammation, and assess the safety of newer treatment approaches.
• Trials in papulopustular acne and papulopustular rosacea are comparing topical treatments with reference products and vehicle controls to measure effectiveness on skin lesions.

The site’s work in this area reflects a strong interest in both everyday dermatology care and the development of improved therapies for chronic skin disease.

Research at ProDerma also includes immune system diseases, with studies centered on chronic spontaneous urticaria, atopic dermatitis, and psoriasis. The main goal is to evaluate whether emerging therapies can better reduce disease activity, improve comfort, and provide longer-lasting relief for patients.

• Chronic spontaneous urticaria studies are assessing whether new treatments can lower hive activity and improve daily symptom control.
• Atopic dermatitis trials are examining both treatment effectiveness and long-term safety in adults, adolescents, and children.
• Psoriasis research is focused on testing candidate therapies that may offer better disease suppression than placebo or standard care.

These investigations highlight the site’s role in advancing treatment options for immune-mediated conditions that often require ongoing management.

The site is also involved in research on parasitic diseases, particularly scabies. This work aims to confirm how well different treatments clear the infection and to support more effective care for patients affected by this highly contagious skin condition.

• Scabies studies are comparing treatment success after topical therapy to help determine the most effective approach for clearing infestation.
• Research in this area is centered on practical treatment outcomes, with attention to symptom resolution and overall clinical effectiveness.

By including scabies research alongside inflammatory skin disorders, ProDerma shows a broad dermatology portfolio that addresses both infectious and immune-related conditions.